Regulus Therapeutics Inc.
RGLS · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $39 | $26 | $17 |
| Short-Term Investments | $16 | $37 | $61 | $77 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $3 |
| Other Curr. Assets | $6 | $7 | $4 | $3 |
| Total Curr. Assets | $72 | $82 | $92 | $100 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $3 |
| Total NC Assets | $3 | $2 | $2 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $75 | $84 | $94 | $104 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $7 | $6 | $4 |
| Total Curr. Liab. | $4 | $7 | $6 | $5 |
| LT Debt | $1 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $0 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $1 |
| Total Liabilities | $6 | $8 | $7 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$569 | -$560 | -$547 | -$533 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $638 | $636 | $633 | $631 |
| Total Equity | $69 | $76 | $87 | $98 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $75 | $84 | $94 | $104 |
| Net Debt | -$48 | -$38 | -$26 | -$16 |